This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
RAN-Domperidone
- Starting date:
- March 6, 2013
- Posting date:
- March 19, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-26225
Recalled Products
A. RAN-Domperidone
Reason
Tablets were found with trace amounts of metal on their surface.
Depth of distribution
Product is distributed to wholesalers and pharmacies in all provinces and territories in Canada.
Affected products
A. RAN-Domperidone
DIN, NPN, DIN-HIM
DIN 02268078Dosage form
Tablet
Strength
10 mg
Lot or serial number
660159, 660160, 660162
Companies
- Recalling Firm
-
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
- Marketing Authorization Holder
-
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA